Business
Cabraal and Central Bank responds to debt default fears
Recent commentary on Sri Lanka’s credit outlook ignores the numerous policy initiatives of the Government of Sri Lanka, which have already started yielding results
The Government of Sri Lanka observes that the concerns expressed in the media in reference to recent reports on Sri Lanka’s ability to service its debt obligations by international banks are one sided, and do not take into consideration the numerous of policy measures that have been introduced to revive the economy and ensure macroeconomic stability. These innovative policy measures are not restricted to traditional debt-based solutions to service the current debt obligations. Measures to build resources through non-debt solutions, the preservation of foreign currency resources and the gradual phasing down of the relative share of foreign debt are already yielding desired results, with a high likelihood of harnessing further improvements during the remainder of the year and beyond.
Certain media reports published recently attempts to raise concerns about Sri Lanka’s ability to honour its debt service obligations, based on backward looking and linear assumptions, thus ignoring the expected outcome of the novel policy regime currently in place. While gross official reserves have moderated somewhat since end December 2020, such moderation is not expected to continue. When all relevant facts are considered, it becomes apparent that the fears raised in certain reports are, in fact, merely hypothetical. The Sri Lankan economy, which is over US dollars 80 billion, has major natural and regular sources of foreign exchange inflows, including merchandise and services exports, workers’ remittances, programme and project related inflows, equity investment, and other financial flows. Aided by the post-COVID revival of the economy, such foreign exchange inflows are projected at US dollars 32 billion in 2021, even without major forms of borrowings, such as floating International Sovereign Bonds (ISBs). These projected inflows are expected to increase by about US dollars 2-3 billion annually in the period ahead with the support of well targeted policies and strategies of the Government. At the same time, authorities will continue to take measures to build up official reserves with the help of measures already implemented and further measures as necessary in the period ahead. It is noteworthy that the Government has launched a major drive towards promoting real inflows of foreign exchange through actively facilitating various merchandise and services exports, in both traditional and non-traditional sectors. The import curtailment measures and the steady recovery in export earnings would continue to improve liquidity in the domestic foreign exchange market. Further, envisaged equity investment flows through the Colombo Port City and Industrial Zones and the reprioritisation of project financing would help reduce the share of foreign debt notably in the period ahead, thereby dispelling concerns about debt sustainability.
In this context, settling the maturing ISBs of US dollars 1.0-1.5 billion, per year, over the medium term, need not be viewed as a major source of concern, given the entire stock of outstanding ISBs account for only 16.7 per cent of Sri Lanka’s total government debt as of end February 2021. It is also stressed that lenders in the majority of 83.3 per cent of the debt stock have raised no concern whatsoever about Sri Lanka’s ability to honour debt obligations. The authorities remain committed to honoring all upcoming debt obligations, leaving zero probability of any form of default on any obligation, which would jeopardise the longstanding relations with stakeholders and the impeccable credit history of the country.
The engagement with the International Monetary Fund (IMF) continues at staff level and as a member state in technical exchanges of know-how. Exploration of liquidity facilitation arrangements with regional central banks is also continuing, with some discussions are at an advanced stage.
As indicated in the Budget 2021, the Government has adopted a novel approach in relation to foreign financing, while enhancing the effectiveness of already secured financing channels, aimed at reducing the share of foreign financing of the budget deficit over the medium term. Reflecting the impact of measures already put in place by the Government, the relative share of outstanding external debt has already declined notably. The Government aims to reduce its external debt over the medium term to around a third of the total debt, and already the share of external debt has declined to around 40 per cent by end 2020 from over 48 per cent at end 2019.
The measures introduced to manage non-essential imports helped ease trade deficit to USD 5,978 million in 2020 from USD 7,997 million in 2019. The trade deficit is further expected to shrink in 2021 to around USD 4 billion. Export facilitation is expected to continue through allowing intermediate goods imports unhindered and promoting domestic value chain improvements, which would result in export earnings of about USD 13 billion in 2021.
Additionally, despite the projections of downturn in workers’ remittances, Sri Lanka recorded an increase of over USD 400 million remittances in 2020 with an aggregate of USD 7.1 billion. The policy measures to further incentivise remittances flows were facilitated with the Budget 2021 announcement of an additional Rs. 2 for conversion of per USD remittance, and the banks were required to sell 10 per cent of such remittance conversion to the Central Bank. The Central Bank has already commenced such absorption of conversions into its foreign exchange reserve. Further arrangements to improve foreign currency liquidity have been introduced, including a mandatory conversion of ¼ of export proceeds.
The Government is also in the process of channeling in official credit sources, with priority being envisaged for policy loans with a significantly high liquidity component. In addition, the commercial external financing component of the already lined-up term financing facility and other market financing components are envisaged in line with Budget 2021.
Sri Lanka Development Bonds (SLDBs) and loans of Overseas Banking Units (OBUs) also remain sources of foreign currency financing mainly from domestic foreign currency earning entities. The recently introduced measures to entice foreign investors to the government securities market and the real economy through an attractive foreign exchange swap arrangement are also likely to help enhance foreign currency inflows in the near term.
Real investment flows to the country remain a promising source based on the Colombo Port City related developments. The land reclamation work had been completed and the required legislation is being finalised. In December 2020, the Sri Lankan conglomerate, LOLC Group, signed an agreement with the Port City developers for a Mixed Development Project valued at USD 1 billion, which is set to break ground in mid-2021.
In this context, the Government reiterates its utmost commitment on meeting its external debt obligations, which will be facilitated not only through direct and indirect financing arrangements but also through highlighted policy measures and the current work plan to increase non-debt creating forex inflows.
The Government wishes to reiterate that even in the midst of various concerns raised by many parties on Sri Lanka’s debt service capability at the height of the COVID-19 pandemic, the Government was able to service its total external debt of around USD 4.3 billion in 2020.
The recent research reports indicate different figures of external debt obligations for 2021. The external debt obligations of the Government for 2021 amount to around USD 3.7 billion including the amortisation payments of USD 2.5 billion. Of this amount, thus far in 2021, the Government has settled over USD 500 million.
Sri Lanka will engage freely with all its investment and development partners and implement the envisaged measures to build up reserves through non-debt creating inflows while reviewing closely the international capital market developments.
Investors are invited to approach the Sri Lankan policy authorities at the highest levels who always remain open for constructive dialogue and will welcome any one-on-one engagement or roadshow discussions, without being dissuaded by premature one-sided opinion expressed without factoring the ground realities and the actual outcomes of policy measures introduced by the Government of Sri Lanka.
Business
Zydus, Sunshine launch US$20 million pharma plant in Horana to boost local drug manufacturing
A market-driven investment backed by confidence in local pharmaceutical manufacturing
Sri Lanka’s drive to strengthen domestic pharmaceutical manufacturing received a major boost last week with the launch of a US$20 million joint venture between India’s Zydus Lifesciences and Sri Lanka’s Sunshine Healthcare to establish a modern pharmaceutical manufacturing facility at the Board of Investment (BOI) zone in Horana.
The foundation stone for the new plant, to be built on nearly four acres, was laid by the leadership of the two companies in the presence of senior executives and stakeholders. The facility will manufacture pharmaceutical products for the local retail market, helping improve the availability of quality medicines while reducing Sri Lanka’s dependence on imports.
The venture, operating as Zydus Sunshine Lifesciences Pvt. Ltd., combines Zydus’ global pharmaceutical manufacturing expertise with Sunshine Healthcare’s extensive distribution network and strong presence in Sri Lanka’s healthcare sector. The project is expected to facilitate technology transfer, create skilled employment, and strengthen the country’s healthcare supply chain.
Speaking at the ceremony, Dr. Sharvil P. Patel, Managing Director of Zydus Lifesciences, said the investment reflected the company’s long-standing commitment to Sri Lanka, where it has operated for more than three decades.
“We have always believed that strong local capabilities are key to resilient healthcare ecosystems,” he said. “Through Zydus Sunshine Lifesciences, we seek to contribute to the development of a stronger pharmaceutical manufacturing base in Sri Lanka by combining global scientific expertise with deep local execution capabilities.”
Dr. Patel added that the project would go beyond manufacturing by creating high-quality employment opportunities across science, technology, healthcare and operations, helping nurture the next generation of talent in Sri Lanka’s pharmaceutical industry.
Sunshine Holdings Deputy Chairman Vish Govindasamy described the venture as a significant progression in Sri Lanka’s future at a time when countries are seeking to secure stable supply chains.
“The establishment of Zydus Sunshine Lifesciences contributes directly to building greater pharmaceutical security for Sri Lanka,” he said. “Together, we are combining global knowledge with local capability to strengthen pharmaceutical manufacturing, healthcare resilience and our commitment to serving the Sri Lankan people.”
Govindasamy noted that the project represents the largest foreign direct investment into Sri Lanka’s pharmaceutical manufacturing sector to date, with the initial equity capital of US$10 million contributed equally by the two partners. Sunshine Healthcare’s participation has been supported by the International Finance Corporation’s US$11 million equity investment made last year to support the company’s growth strategy.
The new manufacturing facility will operate under the oversight of the BOI, with the Ministry of Health and the National Medicines Regulatory Authority providing regulatory supervision. All products manufactured at the plant will comply with NMRA standards and applicable pricing regulations.
The investment comes as Sri Lanka continues efforts to expand local production of essential medicines following recent economic challenges that exposed vulnerabilities in import-dependent supply chains. By increasing domestic manufacturing capacity, the partners expect the project to improve medicine availability, strengthen supply security and support the country’s broader healthcare resilience while generating high-value employment and industrial growth.
The foundation stone ceremony marked the formal commencement of construction, with both partners expressing confidence that the venture would play a meaningful role in advancing Sri Lanka’s long-term healthcare and manufacturing ambitions.
Unlike many local pharmaceutical manufacturers that operate under government buy-back agreements guaranteeing sales to the public health system, Zydus Sunshine Lifesciences will initially rely entirely on Sri Lanka’s private healthcare market. The partners are betting that locally manufactured, high-quality medicines can successfully replace imported products, making the venture commercially viable without state purchase guarantees. However, Sunshine Holdings Deputy Chairman Vish Govindasamy told The Island Financial Review that the company would welcome opportunities to supply the government sector as well, should the authorities choose to procure its products in the future.
By Sanath Nanayakkare
Business
Lanka Hospitals celebrates 2025 milestones at Pulse of Excellence Awards
The Lanka Hospitals Corporation PLC successfully hosted its exclusive “Pulse of Excellence” awards ceremony recently. The event was organized to recognize and celebrate the institution’s remarkable milestone achievements and outstanding overall performance in 2025.
The ceremony was graced by Dr. Nalinda Jayatissa, Minister of Health and Mass Media and Chief Government Whip, who attended as the Chief Guest and delivered a special address. During his address, the Minister highlighted the institution’s profound contribution to the country, stating: “These achievements are now an integral part of the hospital’s enduring legacy and a testament to its vital role within our nation’s healthcare sector. Lanka Hospitals has consistently demonstrated that true medical excellence is achieved when world-class clinical standards are driven by a genuine, compassionate duty of care toward the people.”
Other distinguished dignitaries in attendance included Dr. Hansaka Wijayamuni, Deputy Minister of Health, and Dr. Priyantha Tennakoon, Director of Private Health Sector Development.
The evening highlighted Lanka Hospitals’ continued commitment to shaping the future of healthcare through a comprehensive awards program, with accolades distributed across several key categories. In the area of Financial and Operational Excellence, departments such as Cardiology, Bariatric Surgery, Neurosciences, Out-Patient, and Radiology were recognized for record-breaking performances in 2025. Notably, the Neurosciences department was commended for achieving the highest number of advanced neurosurgical procedures during the year.
Furthermore, National and International Excellence Awards were presented to the Departments of Finance, Quality Assurance, Infection Prevention and Control, and Marketing. A significant highlight in this category was the hospital’s prestigious nomination by the World Health Organization (WHO) as the first private mentor hospital for Antimicrobial Stewardship in Sri Lanka.
The ceremony also celebrated leadership and dedication. A highly anticipated Lifetime Service Excellence Award was presented to Mr. Sunil Gamage, Chief Ward Master, in recognition of his enduring commitment and service. Additionally, special recognition was bestowed upon Lanka Hospitals Diagnostics (Pvt) Ltd. in honor of its outstanding service excellence and exceptional financial performance throughout the year.
A major milestone of the evening was the official launch of the LHD Mobile Laboratory Service, which was ceremonially inaugurated during the event.
Business
Ceylon Green Life Plantation expands internationally with Malaysia greenhouse venture
Ceylon Green Life Plantation (CGLP) has marked a significant milestone in its growth journey by launching its first international agricultural venture in Malaysia, reinforcing its commitment to modern, sustainable farming and global market expansion. The company recently announced the commencement of a large-scale greenhouse cultivation project in Malaysia, which is expected to create new opportunities for Sri Lankan agricultural expertise while strengthening regional agricultural collaboration.
Implemented with the support of the Malaysian Government, the initial phase of the project will be carried out on a fifty-acre land allocation. The venture will utilise advanced greenhouse technology, modern cultivation methods and high-yield seed varieties to produce vegetables tailored to the demands of the Malaysian market.
CGLP Founder and Chairman Dr. Malan Francis Peter said the initiative represents a major step towards positioning Sri Lankan agricultural knowledge and expertise on the international stage. “This project provides access to advanced agricultural technologies, improved cultivation practices and a ready market for produce. It creates opportunities not only for our organisation but also for Sri Lankan farmers and agricultural professionals who can benefit from international exposure and knowledge transfer,” he said.
-
Opinion6 days agoRanasinghe Premadasa: The man who would not take ‘No’ for an answer
-
News2 days agoAnother 1,132 Sri Lankan Personnel to be deployed for United Nations Peacekeeping Missions
-
Opinion5 days agoSri Lanka’s national security: Justice, reconciliation, and forward-looking vigilance
-
News8 hours agoLAWASIA warns against ad hoc initiative to increase judges’ retirement ages
-
News6 days agoUS Assistant Secretary of State for South and Central Asian Affairs meets President
-
News3 days agoKelaniya emerges as highest ranked Lankan uni in Times Higher Education Sustainability Impact Ratings
-
Opinion4 days agoA triumph for Pakistan’s skilled diplomacy at Iran-US talks
-
Editorial6 days agoFCID’s big catch
